SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations

Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, Marek Kochańczyk, Tomasz Lipniacki
doi: https://doi.org/10.1101/2020.12.28.20248906

Data Availability

All data used in this study are referenced and gathered in the supplementary data set S1. GISAID: www.gisaid.org; UK.GOV: https://coronavirus.data.gov.uk/details/cases

Back to top
Posted February 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations
Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, Marek Kochańczyk, Tomasz Lipniacki
medRxiv 2020.12.28.20248906; doi: https://doi.org/10.1101/2020.12.28.20248906
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area